Featured
-
-
Review Article |
A review of vascular endothelial growth factor and its potential to improve functional outcomes following spinal cord injury
- Cameron Zamanian
- , Gloria Kim
- & Mohamad Bydon
-
Article |
Anti-inflammatory effects of Metformin improve the neuropathic pain and locomotor activity in spinal cord injured rats: introduction of an alternative therapy
- Khashayar Afshari
- , Amir Dehdashtian
- & Ahmad Reza Dehpour
-
-
Article |
Delivery of neostigmine and glycopyrrolate by iontophoresis: a nonrandomized study in individuals with spinal cord injury
- Mark A. Korsten
- , Brian L. Lyons
- & William A. Bauman
-
Original Article |
Dopamine D1 receptor agonist A-68930 inhibits NLRP3 inflammasome activation and protects rats from spinal cord injury-induced acute lung injury
- W Jiang
- , M Li
- & L Zhu
-
Original Article |
Effect of detrusor botulinum toxin a injection on urothelial dysfunction in patients with chronic spinal cord injury: a clinical and immunohistochemistry study before and after treatment
- S-F Chen
- , C-H Chang
- & H-C Kuo
-
Original Article |
Quercetin suppresses NLRP3 inflammasome activation and attenuates histopathology in a rat model of spinal cord injury
- W Jiang
- , Y Huang
- & L Zhu
-
Original Article |
Effects of calcitriol on experimental spinal cord injury in rats
- K-l Zhou
- , D-h Chen
- & X-l Zhang
-
Original Article |
EGb761 improves histological and functional recovery in rats with acute spinal cord contusion injury
- M Yan
- , Y-w Liu
- & Z-j Luo
-
Original Article
| Open AccessRationale, design and critical end points for the Riluzole in Acute Spinal Cord Injury Study (RISCIS): a randomized, double-blinded, placebo-controlled parallel multi-center trial
- M G Fehlings
- , H Nakashima
- & B Kopjar
-
Original Article |
Bosentan protects the spinal cord from ischemia reperfusion injury in rats through vascular endothelial growth factor receptors
- S Gong
- , Z Seng
- & X He
-
Original Article
| Open AccessTwo phase 3, multicenter, randomized, placebo-controlled clinical trials of fampridine-SR for treatment of spasticity in chronic spinal cord injury
- D D Cardenas
- , J F Ditunno
- & A R Blight
-
Original Article |
The effect of long-term oral tadalafil treatment on corpus cavernosum function in an experimental spinal cord transection rat model
- S Toksoz
- , S R Erdem
- & U Keskin
-
Review |
Neurogenic detrusor overactivity in adults: a review on efficacy, tolerability and safety of oral antimuscarinics
- H Madersbacher
- , G Mürtz
- & M Stöhrer
-
Original Article |
Effects of solifenacin in patients with neurogenic detrusor overactivity as a result of spinal cord lesion
- J Krebs
- & J Pannek
-
Original Article |
Increase in soluble CD95L during subacute phases after human spinal cord injury: a potential therapeutic target
- B Biglari
- , A Büchler
- & A Moghaddam
-
Original Article |
The emulsified perfluorocarbon Oxycyte improves spinal cord injury in a swine model of decompression sickness
- R T Mahon
- , C R Auker
- & A A Hall
-
Case Report |
Effects of chronic baclofen use on active movement in an individual with a spinal cord injury
- C Angeli
- , J Ochsner
- & S Harkema
-
Original Article |
Transient ischemia induces massive nuclear accumulation of SUMO2/3-conjugated proteins in spinal cord neurons
- Z Wang
- , R Wang
- & W Yang
-
Original Article |
Contrasting effects of cord injury on intravenous and oral pharmacokinetics of diclofenac: a drug with intermediate hepatic extraction
- L Cruz-Antonio
- , J Arauz
- & G Castañeda-Hernández
-
Original Article |
Evaluation of methods to estimate glomerular filtration rate versus actual drug clearance in patients with chronic spinal cord injury
- J P Lee
- & A T Dang
-
Review |
Spinal cord injury sequelae alter drug pharmacokinetics: an overview
- H Mestre
- , T Alkon
- & A Ibarra
-
Original Article |
The administration of high-dose methylprednisolone for 24 h reduced muscle size and increased atrophy-related gene expression in spinal cord-injured rats
- Y Wu
- , J Hou
- & C P Cardozo
-
Original Article |
Effects of iloprost and piracetam in spinal cord ischemia–reperfusion injury in the rabbit
- E Kalkan
- , F Keskin
- & O Cicek
-
Original Article |
A three-month, open-label, single-arm trial evaluating the safety and pharmacokinetics of oral lithium in patients with chronic spinal cord injury
- Y W Wong
- , S Tam
- & W Young
-
Original Article |
A phase 2 autologous cellular therapy trial in patients with acute, complete spinal cord injury: pragmatics, recruitment, and demographics
- L A T Jones
- , D P Lammertse
- & D A Snyder